With 18.46 million shares changed hands, the volume of the stock remained heavier than its average volume of 15.92 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.75 whereas the lowest price it dropped to was $0.623. The 52-week range on PSTV shows that it touched its highest point at $2.67 and its lowest point at $0.24 during that stretch. It currently has a 1-year price target of $6.17. Beta for the stock currently stands at 0.94.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PSTV was down-trending over the past week, with a drop of -18.64%, but this was up by 11.09% over a month. Three-month performance dropped to -44.36% while six-month performance fell -52.48%. The stock lost -65.00% in the past year, while it has lost -43.39% so far this year. A look at the trailing 12-month EPS for PSTV yields -2.06 with Next year EPS estimates of -0.69. For the next quarter, that number is -0.25. This implies an EPS growth rate of 60.68% for this year and 10.43% for next year. EPS is expected to grow by 49.80% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 46.51%.
Float and Shares Shorts:
At present, 17.00 million PSTV shares are outstanding with a float of 16.57 million shares on hand for trading. On 2025-03-31, short shares totaled 1.25 million, which was 736.0 higher than short shares on 1740700800. In addition to Dr. Marc H. Hedrick M.B.A., M.D. as the firm’s President, CEO & Director, Mr. Andrew J. Sims CPA serves as its VP of Finance & CFO.
Institutional Ownership:
Through their ownership of 0.11432999 of PSTV’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-12-31, PSTV reported revenue of $0.0 and operating income of -$3900000.0. The EBITDA in the recently reported quarter was -$3743000.0 and diluted EPS was $nan.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With PSTV analysts setting a high price target of 19.0 and a low target of 4.0, the average target price over the next 12 months is 9.375. Based on these targets, PSTV could surge 2823.08% to reach the target high and rise by 515.38% to reach the target low. Reaching the average price target will result in a growth of 1342.31% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.68541 being high and -$2.0401 being low. For PSTV, this leads to a yearly average estimate of -$1.865. Based on analyst estimates, the high estimate for the next quarter is -$0.1 and the low estimate is -$0.45. The average estimate for the next quarter is thus -$0.31.
